4.7 Article

Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study

Journal

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
Volume 7, Issue 3, Pages 312-321

Publisher

WILEY
DOI: 10.1002/jcsm.12076

Keywords

Skeletal muscle mass; Sarcopenia; Sarcopenic obesity; Older adults

Funding

  1. United States National Institute on Aging's Division of Behavioral and Social Research [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01-AG034479, R21-AG034263]
  2. WHO's Department of Health Statistics and Information Systems
  3. European Community [223071]
  4. Instituto de Salud Carlos III-FIS [PS09/00295, PS09/01845]
  5. Spanish Ministry of Science and Innovation ACI-Promociona [ACI2009-1010]
  6. Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III
  7. Foundation for Education and European Culture (IPEP)
  8. Miguel Servet contract [CP13/00150]
  9. ISCIII-General Branch Evaluation and Promotion of Health Research
  10. European Regional Development Fund (ERDF-FEDER)
  11. Instituto de Salud Carlos III (Spain) [CD12/00429]

Ask authors/readers for more resources

BackgroundThe aim of this study was to evaluate the factors associated with low skeletal muscle mass (SMM), sarcopenia, and sarcopenic obesity using nationally representative samples of people aged 65years from diverse geographical regions of the world. MethodsData were available for 18363 people aged 65years who participated in the Collaborative Research on Ageing in Europe survey conducted in Finland, Poland, and Spain, and the World Health Organization Study on global AGEing and adult health survey conducted in China, Ghana, India, Mexico, Russia, and South Africa, between 2007 and 2012. A skeletal muscle mass index (SMI) was created to reflect SMM. SMM, SMI, and percent body fat (%BF) were calculated with specific indirect population formulas. These estimates were based on age, sex, weight, height, and race. Sarcopenia and sarcopenic obesity were defined with specific cut-offs. ResultsThe prevalence of sarcopenia ranged from 12.6% (Poland) to 17.5% (India), and that of sarcopenic obesity ranged from 1.3% (India) to 11.0% (Spain). Higher %BF was associated with lower SMM in all countries, and with sarcopenia in five countries (p<0.001). Compared to high levels of physical activity, low levels were related with higher odds for sarcopenia [OR 1.36 (95%CI 1.11-1.67)] and sarcopenic obesity [OR 1.80 (95%CI 1.23-2.64)] in the overall sample. Also, a dose-dependent association between higher numbers of chronic diseases and sarcopenic obesity was observed. ConclusionsPhysical activity and body composition changes such as high %BF are key factors for the prevention of sarcopenia syndrome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available